Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers

Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and... Pharm Res (2018) 35: 138 https://doi.org/10.1007/s11095-018-2416-3 RESEARCH PAPER Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers 1,2 3,4 4 2 5 6 6 Issey Takehara & Takashi Yoshikado & Keiko Ishigame & Daiki Mori & Ken-ichi Furihata & Nobuaki Watanabe & Osamu Ando & 2 4 2 Kazuya Maeda & Yuichi Sugiyama & Hiroyuki Kusuhara Received: 13 January 2018 /Accepted: 22 April 2018 /Published online: 10 May 2018 # Springer Science+Business Media, LLC, part of Springer Nature 2018 ABSTRACT reasonably correlated with that of pitavastatin (r = Purpose To evaluate association of the dose-dependent effect 0.73) and with the AUC of fluvastatin (r = 0.62) 0–4h of rifampicin, an OATP1B inhibitor, on the plasma concen- andsufficientlywiththe AUC of rosuvastatin 0–24h tration–time profiles among OATP1B substrates drugs and (r = 0.32). The AUC of GCDCA-S was reasonably 0–24h endogenous substrates. correlated with those of direct bilirubin (r =0.74) and Methods Eight healthy volunteers received atorvastatin coproporphyrin I (r = 0.80), and sufficiently with that of (1 mg), pitavastatin (0.2 mg), rosuvastatin (0.5 mg), and total bilirubin (r = 0.30). The AUC of GCDCA-S, 0–24h fluvastatin (2 mg) alone or http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pharmaceutical Research Springer Journals

Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers

Loading next page...
 
/lp/springer_journal/comparative-study-of-the-dose-dependence-of-oatp1b-inhibition-by-mp0e0K5z5S
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Biomedicine; Pharmacology/Toxicology; Pharmacy; Biochemistry, general; Medical Law; Biomedical Engineering
ISSN
0724-8741
eISSN
1573-904X
D.O.I.
10.1007/s11095-018-2416-3
Publisher site
See Article on Publisher Site

Abstract

Pharm Res (2018) 35: 138 https://doi.org/10.1007/s11095-018-2416-3 RESEARCH PAPER Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers 1,2 3,4 4 2 5 6 6 Issey Takehara & Takashi Yoshikado & Keiko Ishigame & Daiki Mori & Ken-ichi Furihata & Nobuaki Watanabe & Osamu Ando & 2 4 2 Kazuya Maeda & Yuichi Sugiyama & Hiroyuki Kusuhara Received: 13 January 2018 /Accepted: 22 April 2018 /Published online: 10 May 2018 # Springer Science+Business Media, LLC, part of Springer Nature 2018 ABSTRACT reasonably correlated with that of pitavastatin (r = Purpose To evaluate association of the dose-dependent effect 0.73) and with the AUC of fluvastatin (r = 0.62) 0–4h of rifampicin, an OATP1B inhibitor, on the plasma concen- andsufficientlywiththe AUC of rosuvastatin 0–24h tration–time profiles among OATP1B substrates drugs and (r = 0.32). The AUC of GCDCA-S was reasonably 0–24h endogenous substrates. correlated with those of direct bilirubin (r =0.74) and Methods Eight healthy volunteers received atorvastatin coproporphyrin I (r = 0.80), and sufficiently with that of (1 mg), pitavastatin (0.2 mg), rosuvastatin (0.5 mg), and total bilirubin (r = 0.30). The AUC of GCDCA-S, 0–24h fluvastatin (2 mg) alone or

Journal

Pharmaceutical ResearchSpringer Journals

Published: May 10, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off